These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3969176

  • 21. [Malignant neuroleptic syndrome treated with bromocriptine].
    Fernández Ballesteros A, Cervero Jiménez M, Marco Martínez J, Martín Joven A.
    Rev Clin Esp; 1993 Jan; 192(1):49. PubMed ID: 8465032
    [No Abstract] [Full Text] [Related]

  • 22. [Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions].
    Onaka A, Aibiki M, Shirakawa Y, Chikano S, Yokono S, Ogli K.
    Masui; 1993 Mar; 42(3):431-4. PubMed ID: 8468790
    [Abstract] [Full Text] [Related]

  • 23. Neuroleptic malignant syndrome.
    Martin ML, Lucid EJ, Walker RW.
    Ann Emerg Med; 1985 Apr; 14(4):354-8. PubMed ID: 3985449
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Neuroleptic malignant syndrome improved by bromocriptine.
    Misra A.
    J Assoc Physicians India; 1991 Apr; 39(4):364. PubMed ID: 1938840
    [No Abstract] [Full Text] [Related]

  • 27. Bromocriptine and neuroleptic malignant syndrome.
    Rosebush PI, Mazurek MF.
    J Clin Psychiatry; 1991 Jan; 52(1):41-2. PubMed ID: 1988419
    [No Abstract] [Full Text] [Related]

  • 28. Algorithms for the treatment of acute side effects induced by neuroleptics.
    Kusumi I, Koyama T.
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S19-22. PubMed ID: 10560893
    [Abstract] [Full Text] [Related]

  • 29. [Malignant neuroleptic syndrome and Clostridium difficile: causal association or mere coincidence?].
    Salas de Zayas R, Cerdeño Gómez C, Dolera Moreno C, Mármol E.
    Med Intensiva; 2012 Oct; 36(1):63. PubMed ID: 22154227
    [No Abstract] [Full Text] [Related]

  • 30. Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs.
    Schvehla TJ, Herjanic M.
    J Clin Psychiatry; 1988 Jul; 49(7):283-4. PubMed ID: 3391983
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M.
    Pediatr Neurosci; 1988 Jul; 12(3):161-4. PubMed ID: 3870437
    [Abstract] [Full Text] [Related]

  • 39. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report.
    Wu YF, Kan YS, Yang CH.
    Gen Hosp Psychiatry; 2011 Jul; 33(3):301.e7-8. PubMed ID: 21601731
    [Abstract] [Full Text] [Related]

  • 40. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M, de Rohan-Chabot P, Elkharrat D, Gajdos P, Bismuth C, Conso F.
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.